BCCs can uptake exogenous monounsaturated FA via CD36, but BCCs are highly dependent on the activity of SCD1 in the absence of exogenous monounsaturated FA, and inhibition of SCD1 and CD36 produces a significant anti-tumor synergy in breast cancer.11 The gene discussed is CD36; the disease is breast carcinoma.